Overview

EPO Deep Tank in Dialysis Subjects

Status:
Completed
Trial end date:
2007-02-01
Target enrollment:
Participant gender:
Summary
Subject incidence of adverse events
Phase:
Phase 3
Details
Lead Sponsor:
Amgen
Treatments:
Epoetin Alfa